CAS 898531-99-2
:Pbs 57
PBS 57
CAS:Prodotto controllatoApplications A galactosylceramide derivative used in the treatment of influenza. PBS-57 has the ability to stimulate both a cell-mediated and humoral immune response. Co-administration of PBS-57 with a vaccine may be used in methods to stimulate one or more of a humoral immune response, a CD4+ T cell response, and a CD8+ cytotoxic T cell response.
References Liu, Y., et al.: J. Immunol. Methods, 312, 34 (2006), Kamijuku, H., et al.: Mucosal Immunology, 1, 208 (2008), Kopecky-Bromberg, S; Vaccine, 27, 3766 (2009),Formula:C50H96N2O9Colore e forma:NeatPeso molecolare:869.305PBS 57
CAS:PBS 57 is a pluripotent cell-derived protein that has been shown to be a potent vaccine adjuvant. PBS 57 is derived from the plasma of pregnant women and contains the following antigenic determinants: glucose, human albumin, and human immunoglobulin G. PBS 57 can stimulate both humoral and cellular immunity in mice with deficiencies in antibody production or T cells. PBS 57 has also been shown to have strong pro-inflammatory cytokine activity, which may be due to its ability to induce galacturonic acid release from macrophages.
Formula:C50H96N2O9Purezza:Min. 95%Peso molecolare:869.31 g/mol

